| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP&CEO Gl.ah.med.den.sur.grp
4 companies
Prange Karen serves as a Director at EMBC and has filed Form 4s across 4 companies. Across recent SEC filings that breaks down to 0 buys and 4 sells. Those positions are worth an estimated $885K at current prices.
Historically, Prange Karen's trades have earned a middling insider score of 62/100 across 4 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +36.6%.
The biggest single holding is ATRC (~$885K) as Director. The recent filings there lean toward selling, a net 13,377 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | ATRC Atricure, Inc. | Director | Sell | 3,564 | $38.80 | $138,283.20 | -13.5% | +58.8% | - | |
| May 20, 2026 | ATRC Atricure, Inc. | Director | Sell | 3,000 | $28.65 | $85,950.00 | -10.2% | +57.8% | - | |
| Mar 5, 2025 | ATRC Atricure, Inc. | Director | Sell | 6,100 | $38.12 | $232,532.00 | -25.5% | -8.2% | -20.0% | |
| Jun 8, 2023 | ATRC Atricure, Inc. | Director | Sell | 713 | $47.89 | $34,145.57 | -4.2% | -6.3% | -53.2% |